103 results on '"Tomino, Yasuhiko"'
Search Results
2. Novel coronavirus disease in patients with end‐stage kidney disease
3. Multicenter laparoscopic evaluation of the peritoneum in peritoneal dialysis patients
4. How to treat patients with chronic kidney disease: With special focus on IgA nephropathy
5. Evaluation of Long-Term Combination Therapy With Peritoneal Dialysis and Hemodialysis
6. Impact of anaemia treatment for left ventricular remodelling prior to initiation of dialysis in chronic kidney disease patients: Efficacy and stability of long acting erythropoietin stimulating agents
7. Gender‐ and disease‐specific urinary thioredoxin in chronic kidney disease patients with or without type 2 diabetic nephropathy
8. Impact of Body Mass Index on Progression of IgA Nephropathy Among Japanese Patients
9. Comparison Between the Fixation of Peritoneal Dialysis Catheters to the Peritoneal Wall and the Conventional Placement Technique: Clinical Experience and Follow-Up of a New Implant Technique for Peritoneal Dialysis Catheters
10. Usefulness of HPLC Assay for Early Detection of Microalbuminuria in Chronic Kidney Disease
11. Predictors of prognosis in IgA nephropathy
12. Rapamycin inhibits transforming growth factor β-induced peritoneal angiogenesis by blocking the secondary hypoxic response
13. Risk of Overestimation of Kidney Function Using GFR-Estimating Equations in Patients with Low Inulin Clearance
14. Successfully maintained hemodialysis for the treatment of chronic renal failure in a patient with Hallopeau-Siemens type recessive dystrophic epidermolysis bullosa
15. Serum Concentration of Complement Components of the Lectin Pathway in Maintenance Hemodialysis Patients, and Relatively Higher Levels of L-Ficolin and MASP-2 in Mannose-Binding Lectin Deficiency
16. Efficacy of adsorbent in delaying dialysis initiation among chronic kidney disease patients
17. Predictive Factors Associated with Left Ventricular Hypertrophy at Baseline and in the Follow‐Up Period in Non‐Diabetic Hemodialysis Patients
18. Immunoglobulin A nephropathy and chronic kidney disease
19. Metabolic impact on serum levels of complement component 3 in Japanese patients
20. Spontaneous animal model, ddY mouse, for studying the pathogenesis and treatment in patients with immunoglobulin A nephropathy
21. Sources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of disease
22. Application of proteomic analysis to renal disease in the clinic
23. STUDIES ON GLOMERULAR IMMUNE SOLUBILIZATION BY COMPLEMENT IN PATIENTS WITH IgA NEPHROPATHY
24. Erratum to: Pioglitazone attenuates TGF‐β1‐induction of fibronectin synthesis and its splicing variant in human mesangial cells via activation of peroxisome proliferator‐activated receptor (PPAR) γ [29 (6) 422–428]
25. Prediction of diagnosis of immunoglobulin a nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading
26. The role of podocytes in proteinuria
27. Hypercomplementemia in adult patients with IgA nephropathy
28. Alteration of IgA1 glycosylation by down-regulation of core�1�?1,3-galactosyltransferase and its molecular chaperone Cosmc by Th2 cytokine
29. Usefulness of a Body Composition Analyzer, InBody 2.0, in Chronic Hemodialysis Patients
30. Glomerular changes in the KK‐Ay/Ta mouse: A possible model for human type 2 diabetic nephropathy
31. Role of mucosal immunity dependent on GATA-3 in glomerular IgA deposition
32. Genetic susceptibility to type 2 diabetic nephropathy in human and animal models
33. Relationship between renal anemia and prognostic stages of IgA nephropathy
34. Using protein/creatinine ratios in random urine
35. Analysis of IgA nephropathy by serial renal biopsies in the ddY mouse: heterogeneous progression of glomerulonephritis
36. Effects of calcium antagonists in hypertensive patients with renal dysfunction: A prospective, randomized, parallel trial comparing benidipine and nifedipine
37. A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine
38. Rapid, simple, and reliable method for the diagnosis of CAPD peritonitis using the new MMP‐9 test kit
39. Relationship between levels of urinary type IV collagen and renal injuries in patients with IgA nephropathy
40. Peroxisome proliferator‐activated receptor γ gene polymorphism is associated with serum triglyceride levels and body mass index in Japanese type 2 diabetic patients
41. ?-trace protein, a new marker of GFR, may predict the early prognostic stages of patients with type 2 diabetic nephropathy
42. Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy
43. Osteodystrophy in Indonesian haemodialysis patients
44. Antibiotics induce apoptosis of human peritoneal mesothelial cells
45. Evaluation of parathyroid hyperplasia by ultrasonographic examination in patients with end‐stage renal failure before and at initiation of dialysis
46. MAP‐LC3, a promising autophagosomal marker, is processed during the differentiation and recovery of podocytes from PAN nephrosis
47. Significance of serum IgA levels and serum IgA/C3 ratio in diagnostic analysis of patients with IgA nephropathy
48. Serum cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy
49. Inhibition of geranylgeranylation suppresses the proliferation of rat cultured mesangial cells
50. Prednisolone-loaded liposome decreases the accumulation of glomerular extracellular matrix and glomerular injury of immunoglobulin A nephropathy in ddY mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.